NASDAQ
BioCryst Pharmaceuticals, Inc. (BCRX) has a price/fcf ratio of 5.00x as of Monday, May 25, 2026. This represents a 128.04% increase compared to its 12-month average of -17.83x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.